SAN DIEGO, Feb. 28, 2017 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage ...
Data Shows Patients Treated with Feraheme® (ferumoxytol) were Less Likely to Develop Severe Hypophosphatemia ...
Biosimilar Hyrimoz® (adalimumab) approved for use in all same indications as reference medicine*** including ...
